Tanager Wealth Management
CADL icon

Tanager Wealth Management’s Candel Therapeutics CADL Stock Holding History

Tanager Wealth Management’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.07M Hold
198,175
– – 0.17% 46
2026
Q2 		$2.04M Hold
198,175
– – 0.18% 44
2026
Q1 		$971K Hold
198,175
– – 0.09% 55
2025
Q4 		$1.12M Hold
198,175
– – 0.11% 51
2025
Q3 		$1.01M Buy
198,175
+1,544
+0.8% +$8.92K 0.11% 55
2025
Q2 		$995K Buy
+196,631
New +$1.01M 0.12% 52

Other funds holding CADL

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Tanager Wealth Management's CADL Position: Q3 2026 in Review

Tanager Wealth Management held its Candel Therapeutics (CADL) position steady in Q3 2026 at 198,175 shares worth $2.07M. The position accounts for 0.17% of the portfolio, ranked #46.

Tanager Wealth Management first reported a position in CADL in Q2 2025 and has held it in 6 quarters since. 21 funds tracked by Wall St. Rank hold CADL as of Q3 2026.

  • Tanager Wealth Management held 198,175 shares of Candel Therapeutics worth $2.07M as of Q3 2026.
  • Tanager Wealth Management left its Candel Therapeutics share count unchanged in Q3 2026.
  • Candel Therapeutics made up 0.17% of Tanager Wealth Management's portfolio in Q3 2026, its #46 holding.
  • Tanager Wealth Management first reported a position in Candel Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • 21 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.

Based on Tanager Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.